v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 5,209,845 $ 4,401,114
Prepaid research and development 233,035 233,035
Prepaid expenses and other current assets 147,074 501,689
Total Current Assets 5,589,954 5,135,838
Other Assets:    
Research and development supplies 1,548,397
Right-to-use asset 270,733
Acquired in-process research and development 455,000
Goodwill 131,495
Fixed assets, net 62,012
Advance to seller 350,000
Intangible assets, net 5,324 5,606
Total Assets 8,062,915 5,491,444
Current Liabilities:    
Accounts payable 477,411 648,739
Accrued expenses 1,689,724 856,639
Lease liability, current 46,092
Total Current Liabilities 2,213,227 1,505,378
Lease liability, net of current portion 227,195
Contingent liabilities 793,490
Total Liabilities 3,233,912 1,505,378
Commitments and contingencies
Shareholders’ Equity    
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at June 30, 2021 and December 31, 2020
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 18,405,726 and 14,393,100 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 18,406 14,393
Additional paid in capital 45,605,084 35,491,462
Accumulated deficit (40,794,487) (31,519,789)
Total Shareholders’ Equity 4,829,003 3,986,066
Total Liabilities and Shareholders’ Equity $ 8,062,915 $ 5,491,444

Source